Bluejay Diagnostics Income Statement (2020-2026) | BJDX

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.25M
Cost of Revenue (Quarter)
0.05M0.07M0.10M0.05M0.08M0.15M0.15M0.15M0.01M305.00753.00816.00
Gross Profit (Quarter)
0.05M
Operating items
Research & Development (Quarter)
0.23M0.44M0.46M0.69M0.76M1.38M1.32M1.35M1.68M1.40M1.29M1.33M1.03M0.55M0.55M0.78M0.89M0.79M0.59M0.81M
Selling, General & Administrative (Quarter)
0.39M0.45M0.82M1.32M1.20M0.15M0.17M0.15M1.07M0.96M1.10M1.09M0.86M0.81M0.93M1.10M1.10M0.83M0.88M1.13M
Other Operating Expenses (Quarter)
0.05M0.07M0.10M0.05M0.08M1.28M0.96M1.18M-2.75M-0.02M687.000.01M305.00753.00816.00
Operating Expenses (Quarter)
0.67M0.96M1.37M2.07M2.03M2.81M2.45M2.68M336.002.34M2.39M2.43M1.90M1.36M1.48M1.89M1.99M1.62M1.46M1.94M
Operating Income (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M
EBIT (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M
Non-operating items
Interest & Investment Income (Quarter)
0.03M0.02M0.06M0.04M0.02M0.03M0.02M0.03M0.02M
Other Non Operating Income (Quarter)
0.06M0.00M0.14M0.09M0.04M-0.08M0.07M0.03M0.01M0.01M0.01M-275.00554.00579.00731.00
Non Operating Income (Quarter)
0.03M-0.24M-0.09M0.05M0.05M-0.15M0.21M0.14M0.09M0.04M0.08M0.10M0.03M-0.12M0.73M0.01M-275.000.02M0.03M731.00
Net income details
EBT (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.40M-2.51M-1.49M-1.45M-1.87M-1.96M-1.60M-1.43M-1.92M
Profit After Tax (Quarter)
0.64M-1.19M-1.46M-2.01M-1.94M-2.96M-2.39M-2.54M-2.81M-2.30M-2.30M-2.33M-2.48M-1.48M-1.43M-1.86M-1.96M-1.60M-1.43M-1.92M
Income from Continuing Operations (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.40M-2.51M-1.49M-1.45M-1.87M-1.96M-1.60M-1.43M-1.92M
Consolidated Net Income (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.40M-2.51M-1.49M-1.45M-1.87M-1.96M-1.60M-1.43M-1.92M
Income towards Parent Company (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.40M-2.51M-1.49M-1.45M-1.87M-1.96M-1.60M-1.43M-1.92M
Net Income towards Common Stockholders (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.40M-2.51M-14.71M-1.43M-1.87M-1.96M-1.60M-1.43M-1.92M
Additional items
EPS (Basic) (Quarter)
-0.15-0.11-0.09-0.10-2.00-2.94-2.36-2.49-22.00-16.67-0.00M-394.76-256.16-76.94-173.57-13.46-1.41-1.01-10.63-1.95
EPS (Weighted Average and Diluted) (Quarter)
-0.16-0.09-0.16-0.10-1.97-2.79-2.43-2.49-22.75-16.67-0.00M-394.76-256.16-76.94-173.57-13.46-1.41-1.01-10.63-1.95
Shares Outstanding (Weighted Average) (Quarter)
4.20M6.32M0.13M20.14M0.00M0.12M1.01M1.02M0.13M0.13M0.00M1.24M3.35M68.63M0.05M0.14M1.39M540.000.45M0.27M
Shares Outstanding (Diluted Average) (Quarter)
4.20M10.49M8.52M20.14M1.01M1.01M1.01M1.02M0.13M0.13M0.00M0.01M0.01M0.07M0.05M0.14M0.97M1.57M0.45M0.98M
EBITDA (Quarter)
-0.67M-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M
Interest Expenses (Quarter)
0.63M0.19M729.00222.00200.00187.00